๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers

โœ Scribed by Ahomadegbe, J C; Tourpin, S; Kaghad, M; Zelek, L; Vayssade, M; Mathieu, M C; Rochard, F; Spielmann, M; Tursz, T; Caput, D


Book ID
110064226
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
212 KB
Volume
19
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Epigenetic silencing of maspin gene expr
โœ Frederick E. Domann; Judd C. Rice; Mary J.C. Hendrix; Bernard W. Futscher ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 135 KB ๐Ÿ‘ 2 views

Maspin is a tumor suppressor whose expression is lost in many advanced breast cancers. Maspin has been shown to inhibit cell motility, invasion and metastasis; however, its precise role in normal mammary epithelium remains to be elucidated. Although expression of maspin mRNA is low or absent in most

Mutational analysis of the p73 Gene in h
โœ Tomotane Shishikura; Shingo Ichimiya; Toshinori Ozaki; Yoshinori Nimura; Hajime ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 163 KB ๐Ÿ‘ 2 views

In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region

Expression and loss of heterozygosity of
โœ Dr. Janos Nagy; James S. Clark; Alexander Cooke; Ailsa M. Campbell; James M. Con ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 498 KB

## Abstract The cโ€met protoโ€oncogene encodes the receptor to hepatocyte growth factorโ€scatter factor (HGFโ€SF), a mesenchymeโ€derived cytokine with cellโ€dissociating, invasion, and angiogenic properties. The expression of cโ€met in breast cancer is the subject of controversy; 111 primary breast cancer